Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunder Mudaliar

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Diabetes Care|July 2, 2003
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetesVictoria Epshteyn, Katherine Morrison, Padma Krishnaswamy, et al.
The American Journal of Managed Care|December 13, 2005
Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac eventDiana Echeverry, Margie Dike, Lois Jovanovic, et al.
Diabetes Care|August 28, 2002
Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profilesSunder Mudaliar, Pharis Mohideen, Reena Deutsch, et al.
Diabetes Technology & Therapeutics|November 19, 2013
Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozinSunder Mudaliar, Robert R Henry, Guenther Boden, et al.
Schizophrenia Research|November 25, 2010
Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptomsHua Jin, David Folsom, Alana Sasaki, et al.
Journal of Clinical Pharmacology|October 11, 2003
Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparisonRobert R Henry, Sunder Mudaliar, Neelima Chu, et al.
Lancet (London, England)|August 3, 2010
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFrank L Greenway, Ken Fujioka, Raymond A Plodkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetesTheodore P Ciaraldi, Sunder Mudaliar, Ario Barzin, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
Association of posttraumatic stress disorder with increased prevalence of metabolic syndromeHua Jin, Nicole M Lanouette, Sunder Mudaliar, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2008
Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trialVanita R Aroda, Theodore P Ciaraldi, Paivi Burke, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Diabetes Care|July 2, 2003
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetesVictoria Epshteyn, Katherine Morrison, Padma Krishnaswamy, et al.
The American Journal of Managed Care|December 13, 2005
Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac eventDiana Echeverry, Margie Dike, Lois Jovanovic, et al.
Diabetes Care|August 28, 2002
Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profilesSunder Mudaliar, Pharis Mohideen, Reena Deutsch, et al.
Diabetes Technology & Therapeutics|November 19, 2013
Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozinSunder Mudaliar, Robert R Henry, Guenther Boden, et al.
Schizophrenia Research|November 25, 2010
Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptomsHua Jin, David Folsom, Alana Sasaki, et al.
Journal of Clinical Pharmacology|October 11, 2003
Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparisonRobert R Henry, Sunder Mudaliar, Neelima Chu, et al.
Lancet (London, England)|August 3, 2010
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFrank L Greenway, Ken Fujioka, Raymond A Plodkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetesTheodore P Ciaraldi, Sunder Mudaliar, Ario Barzin, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
Association of posttraumatic stress disorder with increased prevalence of metabolic syndromeHua Jin, Nicole M Lanouette, Sunder Mudaliar, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2008
Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trialVanita R Aroda, Theodore P Ciaraldi, Paivi Burke, et al.
Pageof 9